Cancer Trials: Patient-Reported, Overall Side Effect Impacts Should Be Measured, US FDA Says

 
• By Sue Sutter
  
Man carrying boxes
Multiple low-grade toxicities can add up to a heavy load of side effects for cancer patients in clinical trials. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D